Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

Doxapram Hydrochloride 2mg/ml Solution for Infusion (2012)

Αναφορές

Βιβλιογραφική αναφορά

Στοιχεία εκδότη

Εκδότης Mercury Pharma Group
Διεύθυνση No. 1 Croydon, 12 - 16 Addiscombe Road, Croydon, Surrey, CR0 0XT, UK
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Name of the medicinal product

Dopram Infusion. Doxapram Hydrochloride 2mg/ml Solution for Infusion.

Qualitative and quantitative composition

Dopram Infusion contains 2 mg Doxapram Hydrochloride BP per ml, in 5% Glucose intravenous infusion BP.

Pharmaceutical form

Sterile solution for intravenous infusion.

Therapeutic indications

Doxapram acts as a ventilatory stimulant and is specifically indicated in the following situations: Acute Respiratory failure: To stimulate ventilation in patients whose blood gas status or clinical condition ...

Posology and method of administration

Dopram infusion is recommended for intravenous use only. Adults and Older patients For the treatment of respiratory failure recommended dosage is 1.5 to 4 mg per minute depending on the condition and response ...

Contraindications

Hypersensitivity to any of the ingredients in the product Severe hypertension Status asthmaticus Coronary artery disease Epilepsy and other convulsive disorders Cerebral oedema Cerebrovascular accident ...

Special warnings and precautions for use

Dopram should be administered concurrently with oxygen to patients with severe irreversible airways obstruction or severely decreased lung compliance, due to the increased work of breathing in these patients. ...

Interaction with other medicinal products and other forms of interaction

Clinical data suggest that concurrent use of aminophylline/theophylline and Dopram may be associated with increased CNS stimulation, agitation, muscle fasciculation and hyperactivity. Care should thus ...

Pregnancy and lactation

Although there is no recognised hazard, this product is not recommended for use in pregnancy unless there are compelling clinical reasons to do so. The physician must weigh the benefit to the risk. It ...

Effects on ability to drive and use machines

Not applicable.

Undesirable effects

Nervous system disorders Dopram may produce adverse effects due to general stimulation of the central, peripheral and autonomic nervous systems: pyrexia, sweating, flushing, salivation, headache, dizziness, ...

Overdose

Overdosage may result in hypertension, tachycardia and other arrhythmias; skeletal muscle hyperactivity including enhanced deep tendon reflexes, and dyspnoea. Serious symptoms of overdosage may include ...

Pharmacodynamic properties

Pharmacotherapeutic group: Respiratory stimulants ATC code: R07AB01 The principal pharmacological action of Dopram is an increase in minute volume produced primarily by an increase in tidal volume and ...

Pharmacokinetic properties

Following an I.V. bolus injection of 1.5mg/kg doxapram, the plasma concentration of doxapram declined in a multi-exponential manner. The mean half-life from 4 – 12 hours was 3.4 hours (range 2.4 – 4.1 ...

Preclinical safety data

Reproduction studies have been performed in rats at doses of up to 1.6 times the human dose and have revealed no evidence of impaired fertility or harm to the foetus associated with the use of doxapram. ...

List of excipients

Glucose Intravenous infusion (BP)

Incompatibilities

Dopram is incompatible with alkaline solutions such as aminophylline, frusemide and thiopentone sodium.

Shelf life

2 years.

Special precautions for storage

Store below 25°C.

Nature and contents of container

Primary container: Viaflex bag in overpouch. Secondary container: Cardboard carton. Presentation: each Viaflex bag contains 500 ml.

Special precautions for disposal and other handling

The VIAFLEX Plus container has an outlet port designed for an administration set with a short single connector. If an administration set with a combined air inlet/fluid path connector has to be used, ensure ...

Marketing authorization holder

MercuryPharm Ltd 4045, Kingswood Road City West Business Park Co Dublin Ireland

Marketing authorization number(s)

PL 15372/0002

Date of first authorization / renewal of the authorization

01 October 1997

Date of revision of the text

March 2012
Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.